Thank you, Dr. Fry.
The issue of risk reduction is a key principle throughout this entire document, the first point being that we should not immediately turn to a pharmacological response to pain or to some ill that someone is facing.
There's a variety of other interventions, whether they be chiropractic, massage, or a variety of other ones. Simply put, I think, in a very blunt form, there was a general sentiment that we are overly reliant on a pharmacological response to dealing with issues that are facing Canadians. That's at the base of this strategy. Second is that if in fact a pharmacological or therapeutic drug is required, that it be an informed manner of prescribing and how that goes into it.
There's a variety of risk reduction measures also built in throughout the strategy, which you'll see under the treatment element around some of the specifics, in terms of naloxone at home and so on and so forth. There's a variety of initiatives, and again, all of them are soundly evidence-based, sourced, and contextualized within the broader context.
Often in this world, which is fraught with a lot of political attention—and which we welcome—sometimes it's laser-picked as to certain issues. To address the strategy writ large, we really have to look at all streams, and we have to ensure that we're collectively advancing the agenda based on what was put on the table. Again, that brings us back to the CCSA role.